General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shichiri M et al. - The potent antiangiogenic properties of oral rifampicin therapy were effective in suppressing cancer progression. It provides a promising new addition to antiangiogenic strategies for designing human cancer therapies. Considering the clinical pharmacokinetics of rifampicin, which enters the enterohepatic circulation and undergoes subsequent hepatic accumulation, it may be especially beneficial as an antitumor agent targeting hepatobiliary tumors.

Related Articles

FDG Hepatic Superscan Caused by Massive Breast Cancer Invasion
Clinical Nuclear Medicine, 10/07/09    Relevance Score: 68%

Effects of chronic hepatitis C infection on the treatment of breast cancer patients
Annals of Oncology, 11/06/09    Relevance Score: 67%

Natural course of HCV infection in childhood cancer survivors
Supportive Care in Cancer, 10/30/09    Relevance Score: 67%

Hairy cell leukemia presenting as multiple discrete hepatic lesions
World Journal of Gastroenterology, 10/06/09    Relevance Score: 66%

Unique Localization of Circulating Tumor Cells in Patients With Hepatic Metastases
Journal of Clinical Oncology, 11/09/09    Relevance Score: 65%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address